Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Treatment of aging vocal folds: surgical approaches

Seino Y, Allen JE.

Curr Opin Otolaryngol Head Neck Surg. 2014 Dec;22(6):466-71. doi: 10.1097/MOO.0000000000000099.

Allopregnanolone and neurogenesis in the nigrostriatal tract

Wang JM.

Front Cell Neurosci. 2014 Aug 12;8:224. doi: 10.3389/fncel.2014.00224. eCollection 2014.

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference

Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ; Parkinson's Disease 2014: Advancing Research, Improving Lives Conference Organizing Committee.

Ann Neurol. 2014 Oct;76(4):469-72. doi: 10.1002/ana.24261. Epub 2014 Sep 23.

Biotechnologically engineered protein binders for applications in amyloid diseases

Haupt C, Fändrich M.

Trends Biotechnol. 2014 Oct;32(10):513-20. doi: 10.1016/j.tibtech.2014.08.004. Epub 2014 Aug 26.

Neurostimulation for traumatic brain injury

Shin SS, Dixon CE, Okonkwo DO, Richardson RM.

J Neurosurg. 2014 Nov;121(5):1219-31. doi: 10.3171/2014.7.JNS131826. Epub 2014 Aug 29.

Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO)

Moore SF, Guzman NV, Mason SL, Williams-Gray CH, Barker RA.

J Parkinsons Dis. 2014;4(4):671-6. doi: 10.3233/JPD-140432.

Rotigotine: the first new chemical entity for transdermal drug delivery

McAfee DA, Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2014 Nov;88(3):586-93. doi: 10.1016/j.ejpb.2014.08.007. Epub 2014 Aug 27.

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration

Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J, Pedraza-Chaverri J.

Cell Signal. 2014 Dec;26(12):2694-701. doi: 10.1016/j.cellsig.2014.08.019. Epub 2014 Aug 28.

Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review

Yeung EYH, Cavanna AE.

Mov Disord Clin Pract. 2014 Sep 1;1(4):307-316. doi: 10.1002/mdc3.12063. eCollection 2014 Dec.

Towards next generation adenosine A(2A) receptor antagonists

Yuan G, Jones GB.

Curr Med Chem. 2014;21(34):3918-35. doi: 10.2174/0929867321666140826115123.

Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia

Ferraro L, Beggiato S, Borroto-Escuela DO, Ravani L, O'Connor WT, Tomasini MC, Borelli AC, Agnati LF, Antonelli T, Tanganelli S, Fuxe K.

Curr Protein Pept Sci. 2014;15(7):681-90. doi: 10.2174/1389203715666140901105253.

Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment

Beggiato S, Antonelli T, Tomasini MC, Borelli AC, Agnati LF, Tanganelli S, Fuxe K, Ferraro L.

Curr Protein Pept Sci. 2014;15(7):673-80. doi: 10.2174/1389203715666140901103205.

Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study

Tassorelli C, De Icco R, Alfonsi E, Bartolo M, Serrao M, Avenali M, De Paoli I, Conte C, Pozzi NG, Bramanti P, Nappi G, Sandrini G.

Parkinsonism Relat Disord. 2014 Nov;20(11):1140-4. doi: 10.1016/j.parkreldis.2014.07.015. Epub 2014 Aug 13.

A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study

Fujioka S, Boeve BF, Parisi JE, Tacik P, Aoki N, Strongosky AJ, Baker M, Sanchez-Contreras M, Ross OA, Rademakers R, Sossi V, Dickson DW, Stoessl AJ, Wszolek ZK.

Parkinsonism Relat Disord. 2014 Nov;20(11):1129-34. doi: 10.1016/j.parkreldis.2014.07.014. Epub 2014 Aug 19.

An overview of adenosine A2A receptor antagonists in Parkinson's disease

Jenner P.

Int Rev Neurobiol. 2014;119:71-86. doi: 10.1016/B978-0-12-801022-8.00003-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias